Correction: Overview of preclinical and phase II clinical studies on Pegmolesatide’s long-term erythropoiesis stimulating effect via EPOR-mediated signal transduction
Saved in:
| Main Authors: | Xiaoying Ma, Zhen Li, Lu Zhang, Hui Qian, Qinkai Chen, Ye Tao, Yunfan Li, Dandan Wang, Zhizhen Hu, Weili Luo, Ping Li, Hai Yu, Changlin Mei, Xueqing Yu, Yuanfeng Zhou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-06-01
|
| Series: | Journal of Translational Medicine |
| Online Access: | https://doi.org/10.1186/s12967-025-06632-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Overview of preclinical and phase II clinical studies on Pegmolesatide’s long-term erythropoiesis stimulating effect via EPOR-mediated signal transduction
by: Xiaoying Ma, et al.
Published: (2025-02-01) -
Randomized Trial of Pegmolesatide for the Treatment of Anemia in Patients With Nondialysis CKD
by: Jianteng Xie, et al.
Published: (2025-03-01) -
WCN25-679 PEGMOLESATIDE FOR THE TREATMENT OF ANEMIA IN NON-DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE PATIENTS: POST-HOC ANALYSIS OF A PHASE 3 TRIAL
by: Xueqing Yu, et al.
Published: (2025-02-01) -
STUDY OF ANTIATHEROSCLEROTIC AND ENDOTHELIOPROTECTIVE ACTIVITY OF PEPTIDE AGONISTS OF EPOR/CD131 HETERORECEPTOR
by: Olesya A. Puchenkova, et al.
Published: (2020-10-01) -
Preoperative Stimulation of Erythropoiesis in Patients with Anemia
by: V. I. Zagrekov, et al.
Published: (2010-04-01)